X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (765) 765
female (487) 487
index medicus (321) 321
middle aged (273) 273
dermatology (244) 244
male (244) 244
adult (240) 240
lupus erythematosus, cutaneous - chemically induced (235) 235
lupus (203) 203
aged (177) 177
rheumatology (162) 162
systemic lupus erythematosus (158) 158
lupus erythematosus, systemic - chemically induced (122) 122
therapy (116) 116
drug eruptions - etiology (105) 105
systemic-lupus-erythematosus (103) 103
lupus erythematosus, cutaneous - pathology (97) 97
rheumatoid-arthritis (94) 94
lupus erythematosus, systemic - drug therapy (89) 89
animals (84) 84
antirheumatic agents - adverse effects (77) 77
adolescent (62) 62
treatment outcome (62) 62
lupus erythematosus, cutaneous - drug therapy (61) 61
skin - pathology (61) 61
immunology (60) 60
drug-induced lupus (59) 59
tumor necrosis factor-alpha - antagonists & inhibitors (59) 59
diagnosis, differential (58) 58
erythematosus (57) 57
lupus erythematosus, cutaneous - diagnosis (57) 57
lupus erythematosus (56) 56
immunosuppressive agents - adverse effects (55) 55
infliximab (54) 54
antibodies, monoclonal - adverse effects (53) 53
autoimmunity (53) 53
risk factors (53) 53
lupus erythematosus, systemic - immunology (52) 52
drug therapy (51) 51
autoimmune diseases (50) 50
arthritis, rheumatoid - drug therapy (49) 49
disease (49) 49
antibodies (47) 47
autoantibodies (47) 47
biopsy (47) 47
immunosuppressive agents - therapeutic use (47) 47
pharmacology & pharmacy (47) 47
rheumatoid arthritis (46) 46
lupus-erythematosus (45) 45
etanercept (44) 44
medicine & public health (44) 44
lupus erythematosus, systemic - complications (43) 43
care and treatment (42) 42
lupus erythematosus, cutaneous - immunology (41) 41
complications and side effects (40) 40
drug eruptions - pathology (38) 38
skin (38) 38
young adult (38) 38
drugs (37) 37
lupus erythematosus, systemic - diagnosis (37) 37
medicine, general & internal (37) 37
psoriasis (36) 36
antifungal agents - adverse effects (35) 35
diagnosis (35) 35
follow-up studies (35) 35
retrospective studies (35) 35
hydroxychloroquine (34) 34
patient (34) 34
abridged index medicus (33) 33
mice (33) 33
arthritis (32) 32
autoimmune diseases - chemically induced (32) 32
time factors (32) 32
lupus erythematosus, systemic - pathology (31) 31
research (31) 31
systemic lupus-erythematosus (31) 31
antibodies, monoclonal - therapeutic use (30) 30
inflammation (30) 30
necrosis-factor-alpha (30) 30
review (30) 30
aged, 80 and over (29) 29
antirheumatic agents - therapeutic use (29) 29
drug eruptions - diagnosis (29) 29
naphthalenes - adverse effects (29) 29
skin diseases - chemically induced (29) 29
thalidomide - adverse effects (29) 29
dermatology & venereal diseases (28) 28
hydroxychloroquine - adverse effects (28) 28
lesions (28) 28
cutaneous lupus erythematosus (27) 27
cutaneous lupus-erythematosus (27) 27
immunoglobulins (27) 27
patients (27) 27
adalimumab (26) 26
analysis (26) 26
antibodies, antinuclear - blood (26) 26
health aspects (26) 26
vasculitis (26) 26
anti-bacterial agents - adverse effects (25) 25
immunoglobulin g - adverse effects (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (759) 759
French (28) 28
German (19) 19
Spanish (6) 6
Danish (3) 3
Hebrew (2) 2
Italian (2) 2
Portuguese (2) 2
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Dermatology, ISSN 0007-0963, 02/2014, Volume 170, Issue 2, pp. 342 - 351
Journal Article
Lupus, ISSN 0961-2033, 10/2009, Volume 18, Issue 11, pp. 935 - 940
Journal Article
Archives of Dermatological Research, ISSN 0340-3696, 1/2009, Volume 301, Issue 1, pp. 99 - 105
Drug-induced lupus erythematosus (DILE) is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation... 
Drug-induced lupus erythematosus | Antinuclear antibodies (ANA) | Medicine & Public Health | Dermatology | Anti-TNFα-induced lupus | Anti-histone antibodies | Subacute cutaneous drug-induced lupus (SCLE) | Drug reactions | RHEUMATOID-ARTHRITIS | AUTOANTIBODIES | ANTINUCLEAR | NECROSIS-FACTOR-ALPHA | INDUCTION | DERMATOLOGY | Anti-TNF alpha-induced lupus | THERAPY | INFLIXIMAB | ASSOCIATION | EPIDEMIOLOGY | PSORIASIS | Antifungal Agents - adverse effects | Antitubercular Agents - adverse effects | Naphthalenes - adverse effects | Antibodies - metabolism | Calcium Channel Blockers - adverse effects | Serositis | Exanthema | Humans | Isoniazid - adverse effects | Interferons - adverse effects | Antihypertensive Agents - administration & dosage | Sodium Chloride Symporter Inhibitors - adverse effects | Arthritis | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Lupus Erythematosus, Systemic - immunology | Sodium Chloride Symporter Inhibitors - administration & dosage | Tumor Necrosis Factor-alpha - immunology | Antibodies - immunology | Lupus Erythematosus, Cutaneous - chemically induced | Procainamide - administration & dosage | Lupus Erythematosus, Cutaneous - immunology | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Anti-Arrhythmia Agents - administration & dosage | Procainamide - adverse effects | Antihypertensive Agents - adverse effects | Hydralazine - adverse effects | Isoniazid - administration & dosage | Lupus Erythematosus, Systemic - diagnosis | Interferons - administration & dosage | Hydralazine - administration & dosage | Animals | Anti-Arrhythmia Agents - adverse effects | Naphthalenes - administration & dosage | Calcium Channel Blockers - administration & dosage | Antitubercular Agents - administration & dosage | Lupus Erythematosus, Systemic - chemically induced | Antifungal Agents - administration & dosage | Lupus Erythematosus, Cutaneous - diagnosis | Lupus | Antigen-antibody reactions | Enzymes | Antigens | Biological products | Antibodies | Viral antibodies | Enzyme inhibitors | Systemic lupus erythematosus | Fluocinolone acetonide | Calcium channel blockers | Diuretics | Kidney diseases | Hydralazine | Index Medicus
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 02/2017, Volume 31, Issue 2, pp. e116 - e117
Journal Article
Drug Safety, ISSN 0114-5916, 5/2011, Volume 34, Issue 5, pp. 357 - 374
Journal Article